Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference

Krystal Biotech (NASDAQ: KRYS) will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 in Boston.

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 in Boston. Company executives will participate in a fireside chat at 3:10 pm ET and hold investor meetings that day. A webcast will be available beginning at 3:10 pm ET and posted on the Investors section of the company website.

Argus Feb 24 session

-2.80% close to close Open Argus

Details

News Market Reaction – KRYS

On Feb 24, the day this news came out, KRYS closed 2.80% below the previous close.

Data tracked by StockTitan Argus for the Feb 24 session.

Market Context

This announcement highlights KRYS’s upcoming presence at the TD Cowen 46th Annual Health Care Confer...

Analysis

This announcement highlights KRYS’s upcoming presence at the TD Cowen 46th Annual Health Care Conference on March 3, 2026, including a 3:10 pm ET fireside chat and investor meetings. Set against a backdrop of recent strong earnings, positive clinical updates, and regulatory designations, the event offers another venue for management to communicate strategy and progress. Investors may watch for any incremental commentary on commercialization trends, pipeline timelines, and previously disclosed financial guidance.

Key Figures

Conference edition: 46th Annual Conference date: March 3, 2026 Fireside chat time: 3:10 pm ET

Conference edition

46th Annual

TD Cowen Health Care Conference

Conference date

March 3, 2026

TD Cowen Health Care Conference in Boston

Fireside chat time

3:10 pm ET

Scheduled company fireside chat

Historical Context

5 past events · Latest: Feb 17

5 events

1. Feb 17

   Earnings results

   24h Move

   +4.1%

   Strong Q4 and FY2025 results with high-margin VYJUVEK revenue and cash build.

2. Feb 10

   Earnings date set

   24h Move

   -0.7%

   Scheduled Q4 and FY2025 earnings release and business update webcast.

3. Feb 09

   Regulatory designation

   24h Move

   -0.1%

   FDA RMAT designation for KB707 in advanced or metastatic NSCLC.

4. Jan 08

   Clinical data update

   24h Move

   +1.0%

   Positive interim KB407 Phase 1 CORAL-1 data in cystic fibrosis patients.

5. Jan 07

   Clinical call scheduled

   24h Move

   -1.2%

   Announcement of Jan 8 investor call to share interim CORAL-1 KB407 data.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the TD Cowen 46th Annual Health Care Conference on March 3, 2026, in Boston. Company executives will take part in a fireside chat scheduled at 3:10 pm ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 3:10 pm ET on Tuesday, March 3, 2026 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:
Stéphane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Krystal Biotech (KRYS) present at the TD Cowen conference on March 3, 2026?

Krystal Biotech will present on March 3, 2026 with a fireside chat at 3:10 pm ET. According to the company, executives will also host investor meetings throughout the day and a webcast of the presentation will be available at 3:10 pm ET on the investor website.

How can investors watch the Krystal Biotech (KRYS) presentation on March 3, 2026?

Investors can watch via a company webcast starting at 3:10 pm ET on March 3, 2026. According to the company, the webcast will be posted in the Investors section of the company website for live viewing and later access.

What is the schedule for Krystal Biotech (KRYS) executives at the TD Cowen 46th Annual Health Care Conference?

Executives will take part in a 3:10 pm ET fireside chat and hold investor meetings throughout March 3, 2026. According to the company, the day includes one scheduled presentation time plus multiple investor meetings arranged by the company.

Will Krystal Biotech (KRYS) provide a replay of its March 3, 2026 TD Cowen presentation?

Yes, a replay will be posted on the company investor website after the live webcast. According to the company, the webcast begins at 3:10 pm ET and the presentation will be made available via the Investors section for later viewing.